Keros Therapeutics, Inc. (NASDAQ:KROS) Receives $88.29 Consensus Target Price from Brokerages
Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) has received an average rating of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy rating. The average twelve-month price objective among analysts that have covered the stock in the last year is […]
More Stories
Brookfield Renewable Partners L.P. (NYSE:BEP) Receives $31.90 Average Price Target from Analysts
Shares of Brookfield Renewable Partners L.P. (NYSE:BEP – Get Free Report) (TSE:BEP) have earned an average rating of “Moderate Buy”...
Analysts Set Carvana Co. (NYSE:CVNA) PT at $155.12
Shares of Carvana Co. (NYSE:CVNA – Get Free Report) have received a consensus rating of “Hold” from the twenty research...
Analysts Set Cintas Co. (NASDAQ:CTAS) Price Target at $197.30
Shares of Cintas Co. (NASDAQ:CTAS – Get Free Report) have earned an average recommendation of “Hold” from the seventeen ratings...
Analysts Set The Kroger Co. (NYSE:KR) PT at $59.36
Shares of The Kroger Co. (NYSE:KR – Get Free Report) have received an average recommendation of “Moderate Buy” from the...
US Targets Houthi Positions in Yemen With Airstrikes
By Chase Smith U.S. forces conducted 15 strikes in Iranian-backed Houthi-controlled areas of Yemen, U.S. Central Command (CENTCOM), which oversees...
Gang attack in Haiti’s Pont Sondé leaves 70 dead
An attack by a notorious gang in the town of Pont Sondé, Haiti, left at least 70 people dead on...